PT UBC Medical Indonesia Tbk(ID:LABS)
Rp123.00+1.00 (+0.82%)
ID:LABS
PT UBC Medical Indonesia Tbk Revenue
Rp123.00
At close:+1.00 (+0.82%)
PT UBC Medical Indonesia Tbk (LABS) Revenue
PT UBC Medical Indonesia Tbk Revenue
PT UBC Medical Indonesia Tbk had a revenue of 55.32B in the quarter ending Sep 30, 2026, with 0.22%. This bring the company's revenue in the last twelve months to 214.40B, Increased 3.17%. In the fiscal year ending Dec 31, 2025, PT UBC Medical Indonesia Tbk had annual revenue of 199.30B with 34.99% growth.
- Revenue (ttm)
- 214.40B
- Revenue Growth
- 21.38%
- P/S Ratio
- 2.42
- Revenue/Employee
- IDR 3,690,650,815
- Employees
- 54
- Market Cap
- IDR 481.90B
Revenue Chart
PT UBC Medical Indonesia Tbk Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 199.30B | 51.66B | 34.99% |
| Mar 31, 2025 | 147.64B | 10.94B | 8.00% |
| Dec 31, 2023 | 136.70B | 43.41B | 46.53% |
| Dec 31, 2022 | 93.29B | -36.67B | -28.22% |
| Dec 31, 2021 | 129.96B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.